RESUMEN

The human immunodeficiency virus type 1 (HIV-1) Nef protein is an important virulence factor. Nef has several functions, including down-modulation of CD4 and class I major histocompatibility complex cell surface expression, enhancement of virion infectivity, and stimulation of viral replication in peripheral blood mononuclear cells. Nef also increases HIV-1 replication in human lymphoid tissue (HLT) ex vivo. We analyzed recombinant and primary nef alleles with highly divergent activity in different in vitro assays to clarify which of these Nef activities are functionally linked. Our results demonstrate that Nef activity in CD4 down-regulation correlates significantly with the efficiency of HIV-1 replication and with the severity of CD4(+) T-cell depletion in HLT. In conclusion, HIV-1 Nef variants with increased activity in CD4 down-modulation would cause severe depletion of CD4(+) T cells in lymphoid tissues and accelerate AIDS progression.

Asunto(s)

Antígenos CD4/análisis , Recuento de Linfocito CD4 , Productos del Gen nef/fisiología , VIH-1/fisiología , Tejido Linfoide/inmunología , Replicación Viral , Humanos , Productos del Gen nef del Virus de la Inmunodeficiencia Humana

RESUMEN

The human immunodeficiency virus type 1 (HIV-1) Nef protein has several independent functions that might contribute to efficient viral replication in vivo. Since HIV-1 adapts rapidly to its host environment, we investigated if different Nef properties are associated with disease progression. Functional analysis revealed that nef alleles obtained during late stages of infection did not efficiently downmodulate class I major histocompatibility complex but were highly active in the stimulation of viral replication. In comparison, functional activity in downregulation of CD4 and enhancement of HIV-1 infectivity were maintained or enhanced after AIDS progression. Our results demonstrate that various Nef activities are modulated during the course of HIV-1 infection to maintain high viral loads at different stages of disease progression. These findings suggest that all in vitro Nef functions investigated contribute to AIDS pathogenesis and indicate that nef variants with increased pathogenicity emerge in a significant number of HIV-1-infected individuals.

Asunto(s)

Síndrome de Inmunodeficiencia Adquirida/virología , Productos del Gen nef/metabolismo , VIH-1/fisiología , VIH-1/patogenicidad , Síndrome de Inmunodeficiencia Adquirida/inmunología , Síndrome de Inmunodeficiencia Adquirida/metabolismo , Alelos , Antígenos CD4/metabolismo , Línea Celular , Estudios de Cohortes , Secuencia de Consenso/genética , Progresión de la Enfermedad , Regulación hacia Abajo , Productos del Gen nef/genética , VIH-1/genética , Antígenos de Histocompatibilidad Clase I/metabolismo , Humanos , Células Jurkat , Modelos Biológicos , Factores de Tiempo , Latencia del Virus , Replicación Viral , Productos del Gen nef del Virus de la Inmunodeficiencia Humana

RESUMEN

Apoptosis or programmed cell death may play a critical role in AIDS pathogenesis through depletion of both CD4(+) and CD8(+) T lymphocytes. Using a reporter virus, a recombinant HIV infectious clone expressing the green fluorescent protein (GFP), apoptosis was measured in productively infected CD4(+) T lymphocytes, in the presence and absence of autologous macrophages. The presence of macrophages in the culture increased the frequency of nonapoptotic GFP-positive productively infected CD4(+) T lymphocytes. The appearance of nonapoptotic productively infected CD4(+) T lymphocytes in the culture required intercellular contacts between macrophages and PBLs and the expression of the HIV Nef protein. The presence of macrophages did not reduce apoptosis when CD4(+) T lymphocytes were infected with a GFP-tagged virus deleted for the nef gene. TNF-alpha (TNF) expressed on the surface of macrophages prevented apoptosis in nef-expressing, productively infected CD4(+) T lymphocytes. Similarly, following TNF stimulation, apoptosis was diminished in Jurkat T cells transfected with a nef-expressing plasmid. TNF stimulation of nef-expressing Jurkat T cells resulted in NF-kappaB hyperactivation, which has been shown to deliver anti-apoptotic signals. Our results indicate that intercellular contacts with macrophages increase the rate of productively infected nonapoptotic CD4(+) T lymphocytes. The survival of productively infected CD4(+) T lymphocytes requires Nef expression as well as activation by TNF expressed on the surface of macrophages and might participate in the formation and maintenance of viral reservoirs in HIV-infected persons.

Asunto(s)

Apoptosis/inmunología , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/virología , Productos del Gen nef/fisiología , VIH-1/inmunología , Activación de Linfocitos/inmunología , Macrófagos/inmunología , Latencia del Virus/inmunología , Animales , Apoptosis/genética , Linfocitos T CD4-Positivos/citología , Linfocitos T CD4-Positivos/metabolismo , Células CHO , Comunicación Celular/genética , Comunicación Celular/inmunología , Células Cultivadas , Cricetinae , Productos del Gen nef/biosíntesis , Productos del Gen nef/genética , Proteínas Fluorescentes Verdes , VIH-1/genética , Humanos , Inmunidad Innata , Células Jurkat , Proteínas Luminiscentes/genética , Activación de Linfocitos/genética , FN-kappa B/genética , FN-kappa B/metabolismo , Transfección , Factor de Necrosis Tumoral alfa/inmunología , Latencia del Virus/genética , Productos del Gen nef del Virus de la Inmunodeficiencia Humana

RESUMEN

Factors accounting for long-term nonprogression may include infection with an attenuated strain of human immunodeficiency virus type 1 (HIV-1), genetic polymorphisms in the host, and virus-specific immune responses. In this study, we examined eight individuals with nonprogressing or slowly progressing HIV-1 infection, none of whom were homozygous for host-specific polymorphisms (CCR5-Delta32, CCR2-64I, and SDF-1-3'A) which have been associated with slower disease progression. HIV-1 was recovered from seven of the eight, and recovered virus was used for sequencing the full-length HIV-1 genome; full-length HIV-1 genome sequences from the eighth were determined following amplification of viral sequences directly from peripheral blood mononuclear cells (PBMC). Longitudinal studies of one individual with HIV-1 that consistently exhibited a slow/low growth phenotype revealed a single amino acid deletion in a conserved region of the gp41 transmembrane protein that was not seen in any of 131 envelope sequences in the Los Alamos HIV-1 sequence database. Genetic analysis also revealed that five of the eight individuals harbored HIV-1 with unusual 1- or 2-amino-acid deletions in the Gag sequence compared to subgroup B Gag consensus sequences. These deletions in Gag have either never been observed previously or are extremely rare in the database. Three individuals had deletions in Nef, and one had a 4-amino-acid insertion in Vpu. The unusual polymorphisms in Gag, Env, and Nef described here were also found in stored PBMC samples taken 3 to 11 years prior to, or in one case 4 years subsequent to, the time of sampling for the original sequencing. In all, seven of the eight individuals exhibited one or more unusual polymorphisms; a total of 13 unusual polymorphisms were documented in these seven individuals. These polymorphisms may have been present from the time of initial infection or may have appeared in response to immune surveillance or other selective pressures. Our results indicate that unusual, difficult-to-revert polymorphisms in HIV-1 can be found associated with slow progression or nonprogression in a majority of such cases.

Asunto(s)

Infecciones por VIH/virología , VIH-1/genética , Polimorfismo Genético , Receptores de Quimiocina , Secuencia de Aminoácidos , Animales , Células Cultivadas , Quimiocina CXCL12 , Quimiocinas CXC/genética , Progresión de la Enfermedad , Productos del Gen gag/metabolismo , Productos del Gen nef/genética , Productos del Gen nef/fisiología , Productos del Gen vpr/metabolismo , Genotipo , Infecciones por VIH/fisiopatología , VIH-1/clasificación , VIH-1/crecimiento & desarrollo , VIH-1/inmunología , Antígenos HLA/clasificación , Antígenos HLA/genética , Haplotipos , Humanos , Macaca mulatta , Datos de Secuencia Molecular , Receptores CCR2 , Receptores CCR5/genética , Receptores de Citocinas/genética , Homología de Secuencia de Aminoácido , Virus de la Inmunodeficiencia de los Simios/genética , Virus de la Inmunodeficiencia de los Simios/fisiología , Productos del Gen gag del Virus de la Inmunodeficiencia Humana , Productos del Gen nef del Virus de la Inmunodeficiencia Humana , Productos del Gen vpr del Virus de la Inmunodeficiencia Humana

RESUMEN

A 36-bp deletion close to the 5' end of NEF that impaired Nef function was found in a long-term nonprogressor with human immunodeficiency virus type 1 (HIV-1) infection. Forms containing an adjacent duplication of 33 bp were also frequently observed. The duplication showed no homology to the deleted region but restored the overall length of the first variable loop of Nef. NEF alleles carrying the duplication were active in class I major histocompatibility complex (MHC-I) down-modulation and enhancement of virus infectivity. However, they showed little activity in CD4 down-regulation and were unable to stimulate viral replication in human peripheral blood mononuclear cells. Our study indicates that the enhancement of virion infectivity and the stimulation of HIV-1 replication in lymphocytes are distinct functions of Nef. Our findings also illustrate the capacity for repair of attenuating deletions in HIV-1 infection and suggest that a selective pressure for Nef-mediated MHC-I down-modulation and/or enhancement of virion infectivity exists.

Asunto(s)

Reparación del ADN , Genes nef , Infecciones por VIH/genética , Sobrevivientes de VIH a Largo Plazo , VIH-1/genética , Adulto , Alelos , Secuencia de Aminoácidos , Estudios de Casos y Controles , Duplicación de Gen , Productos del Gen nef/genética , Infecciones por VIH/epidemiología , Antígenos de Histocompatibilidad Clase I/biosíntesis , Homosexualidad , Humanos , Londres/epidemiología , Masculino , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido , Productos del Gen nef del Virus de la Inmunodeficiencia Humana

RESUMEN

Treatment of HIV-1-infected individuals with a combination of anti-retroviral agents results in sustained suppression of HIV-1 replication, as evidenced by a reduction in plasma viral RNA to levels below the limit of detection of available assays. However, even in patients whose plasma viral RNA levels have been suppressed to below detectable levels for up to 30 months, replication-competent virus can routinely be recovered from patient peripheral blood mononuclear cells and from semen. A reservoir of latently infected cells established early in infection may be involved in the maintenance of viral persistence despite highly active anti-retroviral therapy. However, whether virus replication persists in such patients is unknown. HIV-1 cDNA episomes are labile products of virus infection and indicative of recent infection events. Using episome-specific PCR, we demonstrate here ongoing virus replication in a large percentage of infected individuals on highly active anti-retroviral therapy, despite sustained undetectable levels of plasma viral RNA. The presence of a reservoir of 'covert' virus replication in patients on highly active anti-retroviral therapy has important implications for the clinical management of HIV-1-infected individuals and for the development of virus eradication strategies.

Asunto(s)

Fármacos Anti-VIH/uso terapéutico , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/virología , Duplicado del Terminal Largo de VIH , VIH-1/genética , Secuencia de Bases , Recuento de Linfocito CD4/efectos de los fármacos , Cartilla de ADN , Quimioterapia Combinada , Infecciones por VIH/inmunología , VIH-1/fisiología , Humanos , Linfocitos/inmunología , ARN Viral/sangre , Valores de Referencia , Inhibidores de la Transcriptasa Inversa/uso terapéutico , Carga Viral , Replicación Viral

RESUMEN

Seven long-term nonprogressors (LTNPs) have been identified in a cohort of 128 human immunodeficiency virus (HIV)-1 infected individuals with hemophilia. Studies included quantitation of virus by polymerase chain reaction, characterization of primary virus isolates in vitro, analysis of lymphocyte surface markers, and measurement of virus-specific cytotoxic T lymphocytes (CTLs). Viruses of LTNPs exhibited slow growth in vivo and in vitro. LTNPs had expansion of CD8 T cells with increased expression of HLA-DR. Intermittent HIV-1-specific CTL effector activity was detected in freshly isolated peripheral blood mononuclear cells of most LTNPs. CTL precursor frequencies were higher in LTNPs than in patients with progressive disease. Virus antigen-specific lymphoproliferation was vigorous in some LTNPs. Thus, LTNPs in this cohort have maintained remarkably low virus burdens and vigorous HIV-1-specific cell-mediated immunity over a 15-year period. The presence of expanded, activated CD8 T cells with cytotoxic effector function in the peripheral blood suggests ongoing viral replication.

Asunto(s)

Infecciones por VIH , Sobrevivientes de VIH a Largo Plazo , VIH-1/genética , VIH-1/fisiología , Hemofilia A/complicaciones , Recuento de Linfocito CD4 , Quimiocinas/genética , Estudios de Cohortes , Infecciones por VIH/complicaciones , Infecciones por VIH/inmunología , Infecciones por VIH/virología , VIH-1/aislamiento & purificación , Humanos , Inmunofenotipificación , Activación de Linfocitos , Reacción en Cadena de la Polimerasa , Polimorfismo Genético , Receptores de Quimiocina/genética , Linfocitos T/inmunología , Linfocitos T Citotóxicos/inmunología , Carga Viral , Replicación Viral

RESUMEN

nef alleles derived from a large number of individuals infected with human immunodeficiency virus type 1 (HIV-1) were analyzed to investigate the frequency of disrupted nef genes and to elucidate whether specific amino acid substitutions in Nef are associated with different stages of disease. We confirm that deletions or gross abnormalities in nef are rarely present. However, a comparison of Nef consensus sequences derived from 41 long-term nonprogressors and from 50 individuals with progressive HIV-1 infection revealed that specific variations are associated with different stages of infection. Five amino acid variations in Nef (T15, N51, H102, L170, and E182) were more frequently observed among nonprogressors, while nine features (an additional N-terminal PxxP motif, A15, R39, T51, T157, C163, N169, Q170, and M182) were more frequently found in progressors. Strong correlations between the frequency of these variations in Nef and both the CD4(+)-cell count and the viral load were observed. Moreover, analysis of sequential samples obtained from two progressors revealed that several variations in Nef, which were more commonly observed in patients with low CD4(+)-T-cell counts, were detected only during or after progression to immunodeficiency. Our results indicate that sequence variations in Nef are associated with different stages of HIV-1 infection and suggest a link between nef gene function and the immune status of the infected individual.

Asunto(s)

Productos del Gen nef/genética , Variación Genética , Infecciones por VIH/virología , VIH-1/genética , Síndrome de Inmunodeficiencia Adquirida/virología , Secuencia de Aminoácidos , Secuencia de Bases , Recuento de Linfocito CD4 , Estudios de Cohortes , ADN Viral , Progresión de la Enfermedad , Productos del Gen nef/química , Genes Virales , Infecciones por VIH/inmunología , Humanos , Datos de Secuencia Molecular , Conformación Proteica , Homología de Secuencia de Aminoácido , Carga Viral , Productos del Gen nef del Virus de la Inmunodeficiencia Humana

RESUMEN

BACKGROUND: The availability of sensitive assays for plasma HIV viral load and the trend toward earlier and more aggressive treatment of HIV infection has led to the inappropriate use of these assays as primary tools for the diagnosis of acute HIV infection. OBJECTIVE: To describe limitations in the use of plasma viral load testing for the diagnosis of HIV infection. DESIGN: Case series. SETTING: Academic medical centers in Providence, Rhode Island, and Worcester, Massachusetts. PATIENTS: Three persons in whom HIV infection was falsely diagnosed by plasma viral load testing. MEASUREMENTS: Laboratory measures and clinical outcomes. RESULTS: Two cases of false-positive results obtained by using branched-chain DNA plasma viral load assays and one case of a false-positive result obtained by using reverse transcriptase-polymerase chain reaction plasma viral load assay are reported. All three plasma viral load tests yielded positive results with low values (1254 copies/mL, 1574 copies/mL, and 1300 copies/mL). Infection with HIV was initially diagnosed in all three patients, but each patient subsequently tested negative by HIV-1 enzyme-linked immunosorbent assay and repeated plasma viral load testing. CONCLUSION: Physicians should exercise caution when using plasma viral load assays to detect primary HIV infection, particularly when the pretest probability of infection is low.

Asunto(s)

Infecciones por VIH/diagnóstico , VIH-1/aislamiento & purificación , Carga Viral , Adulto , Relación CD4-CD8 , Niño , Protocolos Clínicos , ADN Viral/sangre , Errores Diagnósticos , Ensayo de Inmunoadsorción Enzimática , Reacciones Falso Positivas , Femenino , Humanos , Masculino , Embarazo , Complicaciones Infecciosas del Embarazo/diagnóstico , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa

Asunto(s)

Infecciones por VIH/virología , VIH-1/genética , Recuento de Linfocito CD4 , ADN Viral/sangre , Progresión de la Enfermedad , Eliminación de Gen , Genes nef , Infecciones por VIH/inmunología , Humanos , Masculino , ARN Viral/sangre

RESUMEN

Two primary human immunodeficiency virus (HIV)-1 biologic clones have been studied extensively in a system using CD4 T cell-enriched peripheral blood lymphocytes and anti-CD4 antibody to measure viral replication kinetics and single-cell cytopathicity. Biologic clones from a person with AIDS replicated to high levels and were cytopathic in the absence of syncytium formation. Unexpectedly, biologic clones from an adult long-term nonprogressor were noncytopathic in spite of similar levels of viral replication. A correlation has recently been demonstrated between reduced mitochondrial viability and cell death in HIV-1-infected cultures. Peripheral blood-derived CD4 T cells infected with the cytopathic clone showed a progressive reduction in mitochondrial viability, while those infected with the noncytopathic clone demonstrated functionally viable mitochondria. These studies demonstrate that primary HIV-1-induced cytopathicity is separable from syncytium formation and replication rate.

Asunto(s)

Infecciones por VIH/virología , VIH-1/fisiología , Replicación Viral , Síndrome de Inmunodeficiencia Adquirida/virología , Adulto , Antígenos CD4/inmunología , Recuento de Linfocito CD4 , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/virología , Linfocitos T CD8-positivos/inmunología , Muerte Celular/fisiología , Células Cultivadas , Efecto Citopatogénico Viral , Productos del Gen env/análisis , Productos del Gen env/genética , Células Gigantes/virología , VIH-1/crecimiento & desarrollo , VIH-1/patogenicidad , Hemofilia A/virología , Humanos , Cinética , Leucocitos Mononucleares/virología , Mitocondrias/fisiología , Reacción en Cadena de la Polimerasa , Provirus/crecimiento & desarrollo , Sobrevivientes

RESUMEN

CEMx174- and C8166-45-based cell lines which contain a secreted alkaline phosphatase (SEAP) reporter gene under the control of a tat-responsive promoter derived from either SIVmac239 or HIV-1(NL4-3) were constructed. Basal levels of SEAP activity from these cell lines were low but were greatly stimulated upon transfection of tat expression plasmids. Infection of these cell lines with simian immunodeficiency virus (SIV) or human immunodeficiency virus type 1 (HIV-1) resulted in a dramatic increase in SEAP production within 48 to 72 h that directly correlated with the amount of infecting virus. When combined with chemiluminescent measurement of SEAP activity in the cell-free supernatant, these cells formed the basis of a rapid, sensitive, and quantitative assay for SIV and HIV infectivity and neutralization. Eight of eight primary isolates of HIV-1 that were tested induced readily measurable SEAP activity in this system. While serum neutralization of cloned SIVmac239 was difficult to detect with other assays, neutralization of SIVmac239 was readily detected at low titers with this new assay system. The neutralization sensitivities of two stocks of SIVmac251 with different cell culture passage histories were tested by using sera from SIV-infected monkeys. The primary stock of SIVmac251 had been passaged only twice through primary cultures of rhesus monkey peripheral blood mononuclear cells, while the laboratory-adapted stock had been extensively passaged through the MT4 immortalized T-cell line. The primary stock of SIVmac251 was much more resistant to neutralization by a battery of polyclonal sera from SIV-infected monkeys than was the laboratory-adapted virus. Thus, SIVmac appears to be similar to HIV-1 in that extensive laboratory passage through T-cell lines resulted in a virus that is much more sensitive to serum neutralization.

Asunto(s)

Genes tat , Duplicado del Terminal Largo de VIH , VIH-1/genética , Regiones Promotoras Genéticas , Secuencias Repetitivas de Ácidos Nucleicos , Virus de la Inmunodeficiencia de los Simios/genética , Fosfatasa Alcalina/biosíntesis , Animales , Anticuerpos Antivirales , Secuencia de Bases , Línea Celular , Cartilla de ADN , Genes Reporteros , Humanos , Cinética , Macaca mulatta , Datos de Secuencia Molecular , Pruebas de Neutralización , Provirus/genética , Proteínas Recombinantes de Fusión/biosíntesis , Síndrome de Inmunodeficiencia Adquirida del Simio/inmunología , Factores de Tiempo , Transfección

RESUMEN

The relationships between primary human immunodeficiency virus type 1 (HIV-1) Gag-specific cytotoxic T lymphocyte (CTL) frequency, virus load, and CD4 T cell loss were evaluated in a group of 46 HIV-1-infected persons with hemophilia. Freshly isolated peripheral blood mononuclear cells in limiting dilution assays were used to measure HIV-1 Gag-specific CTL frequencies. Concurrent measurements of virus load and lymphocyte surface markers were obtained. No correlation between Gag-specific CTL frequency and concurrent CD4 cell count was observed. A significant inverse relationship was observed between HIV-1 Gag-specific CTL frequency and provirus load as measured by polymerase chain reaction. Subjects with higher CTL frequencies were found to have more stable CD4 cell counts over time. These results provide additional evidence to support the concept that the predominant role of this virus-specific cellular immune response is to limit viral replication and CD4 cell loss in HIV-1 infection.

Asunto(s)

VIH-1/inmunología , Linfocitos T Citotóxicos/inmunología , Adolescente , Adulto , Recuento de Linfocito CD4 , Niño , Productos del Gen gag/inmunología , Humanos , Masculino , Persona de Mediana Edad

RESUMEN

Different rates of disease progression may be associated with different human immunodeficiency virus type 1 (HIV-1) promoter and/or transactivator activities. We therefore analyzed the sequences and activities of the first exon of Tat, tat1, and the promoter/trans-acting responsive (TAR) regions amplified directly from peripheral blood mononuclear cells obtained from five long-term nonprogressors and eight progressing HIV-1-infected individuals. The majority of tat1 alleles and promoter/TAR regions from all patients were intact and showed comparable activities in transient reporter assays. A substantial number of point mutations and some length variations were observed in the promoter/TAR region. In a single nonprogressor, the Sp1 binding site 3 was consistently altered and the transcriptional activity in the presence of Tat was diminished. Some LTR clones from a rapid progressor contained a fourth Sp1 binding site, which was associated with an elevated basal promoter activity. These data suggest that defects in the promoter/TAR region or tat1 are rare and that different promoter/transactivator activities are not commonly associated with different progression rates.

Asunto(s)

Genes tat , Infecciones por VIH/virología , Duplicado del Terminal Largo de VIH , VIH-1/genética , Regiones Promotoras Genéticas , Alelos , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Células COS , ADN Viral , Progresión de la Enfermedad , Humanos , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido , Homología de Secuencia de Ácido Nucleico , Activación Transcripcional

RESUMEN

A large number of nef alleles were obtained from peripheral blood mononuclear cells (PBMC) of four long-term nonprogressing survivors of human immunodeficiency virus type 1 (HIV-1) infection and from five individuals with progressive HIV-1 infection. These primary nef alleles were characterized by DNA sequence analysis and for their ability to downregulate CD4 surface expression. Intact nef open reading frames that directed the expression of Nef protein were recovered from all of the individuals. Most of the Nef proteins derived from three of four individuals with nonprogressive infection and from all five individuals with progressive infection were functional as judged by their ability to induce a decrease in surface CD4 expression. In contrast, one individual with nonprogressive HIV-1 infection yielded an unusually high frequency of disrupted nef open reading frames and Nef proteins defective for CD4 downregulation. Approximately 70% of the nef clones obtained from the PBMC of this individual at eight time points over a 12-year period were disrupted or defective for CD4 downregulation. While functional Nef proteins were demonstrated early in the course of infection (1983), functional nef alleles have surprisingly not come to predominate over time in PBMC DNA in this individual.

Asunto(s)

Alelos , Genes nef , Infecciones por VIH/virología , VIH-1/genética , Secuencia de Aminoácidos , Antígenos CD4/metabolismo , ADN Viral , Estudios de Seguimiento , Frecuencia de los Genes , VIH-1/metabolismo , Humanos , Células Jurkat , Datos de Secuencia Molecular , Mutación , Filogenia , Homología de Secuencia de Aminoácido , Sobrevivientes

RESUMEN

We describe a case of aggressive Bartonella henselae endocarditis in an immunocompetent man who owned a cat. Aortic valve replacement was required, and his infection was diagnosed by histology, serology, and polymerase chain reaction analysis. The manifestations of his disease included mediastinal lymphadenopathy, glomerulonephritis, myocarditis, and a petechial rash; the unusual finding of a positive titer of c-antineutrophil cytoplasmic antibodies was noted. Serological titers were markedly elevated for > 1 year despite clinical improvement.

Asunto(s)

Válvula Aórtica/microbiología , Bartonella henselae/aislamiento & purificación , Enfermedad por Rasguño de Gato/complicaciones , Endocarditis Bacteriana/microbiología , Adulto , Animales , Animales Domésticos , Anticuerpos Antibacterianos/análisis , Enfermedad por Rasguño de Gato/diagnóstico , Enfermedad por Rasguño de Gato/etiología , Enfermedad por Rasguño de Gato/inmunología , Gatos , ADN Bacteriano/análisis , Endocarditis Bacteriana/diagnóstico , Endocarditis Bacteriana/inmunología , Humanos , Inmunocompetencia , Masculino

RESUMEN

Nevirapine, a potent nonnucleoside reverse transcriptase inhibitor, produces a transient antiviral effect at < or = 200 mg/day due to the selection of resistant virus. To examine if higher levels of nevirapine could produce sustained antiviral activity, its safety, pharmacokinetics, and antiviral activity at 400 mg/day were studied in 21 patients. There was a rapid reduction in immune complex-dissociated p24 antigen and serum human immunodeficiency virus RNA concentration in all patients, and 8 of 10 patients had > 50% reduction at 8 weeks. Nevirapine-resistant virus was isolated from all subjects tested at 12 weeks: The mean plasma trough level (4.0 micrograms/mL [15.8 microM]) exceeded the mean IC50 of resistant virus. Rash developed in 48% of patients and was a dose-limiting toxicity factor in 6. These data suggest that clinical testing of potent antiviral compounds that select for drug-resistant virus is justified to determine if serum levels of drug sufficient to overcome resistant virus can be attained.

Asunto(s)

Antivirales/uso terapéutico , Infecciones por VIH/tratamiento farmacológico , Piridinas/uso terapéutico , Inhibidores de la Transcriptasa Inversa , Adulto , Proteína p24 del Núcleo del VIH/análisis , Humanos , Persona de Mediana Edad , Nevirapina , Piridinas/efectos adversos , Piridinas/farmacocinética , ARN Viral/análisis

RESUMEN

In these Phase I/II open-label clinical trials, 62 persons with human immunodeficiency virus type 1 (HIV-1) infection and CD4+ cell counts < 400/mm3 received nevirapine at doses of 12.5, 50, and 200 mg/day, alone or in combination with zidovudine, 200 mg q8h. Nevirapine was well tolerated in the doses tested. Mean steady-state trough levels were 0.23, 1.1, and 1.9 micrograms/ml for the 12.5, 50, and 200 mg/day doses, respectively. Early suppression of p24 antigen levels and increase in CD4+ cell count were reversed following rapid emergence of virus less susceptible to nevirapine. Resistant strains were isolated from all participants by 8 weeks. Nevertheless, reduction of p24 antigen levels to < 50% of baseline values persisted for 12 weeks or more in four of seven persons who received 200 mg nevirapine/day in combination with zidovudine: these individuals had been antigenemic on long-term zidovudine therapy. This study demonstrates a direct relationship between drug resistance and effects on surrogate markers in HIV-1 infection.

Asunto(s)

Antivirales/uso terapéutico , Infecciones por VIH/tratamiento farmacológico , VIH-1/efectos de los fármacos , Piridinas/uso terapéutico , Zidovudina/uso terapéutico , Adulto , Recuento de Linfocito CD4 , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Femenino , Proteína p24 del Núcleo del VIH/sangre , Infecciones por VIH/sangre , Humanos , Masculino , Persona de Mediana Edad , Nevirapina , Piridinas/efectos adversos , Piridinas/farmacocinética , Inhibidores de la Transcriptasa Inversa , Estados Unidos

Asunto(s)

Eliminación de Gen , Genes nef , Infecciones por VIH/virología , VIH-1/genética , Adulto , Secuencia de Bases , ADN Viral/análisis , Progresión de la Enfermedad , Seropositividad para VIH/virología , Humanos , Masculino , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Replicación Viral

RESUMEN

A detailed, longitudinal study was undertaken to investigate the immunological and virological features of an individual with hemophilia infected with human immunodeficiency virus type-1 (HIV-1) for 10 years without disease. Methods applied to serial samples of peripheral blood included Western blot analysis, neutralizing antibody assays, antibody-dependent cell-mediated cytotoxicity (ADCC) titration, HIV-1 specific cytotoxic T lymphocyte (CTL) assays, viral cultures, and PCR with sequence analysis of viral regulatory genes. Strong antibody responses against HIV-1 antigens as measured by Western blot and ADCC assays have persisted throughout infection. Repeated attempts to isolate HIV-1 using sensitive culture techniques and to demonstrate viremia with standard PCR methods have failed. Using the "booster" PCR technique, a period of viremia in peripheral blood mononuclear cells was demonstrated. Concurrent with detection of circulating virus, titers of neutralizing antibodies and circulating HIV-1-specific CTLs became measurable. Sequencing studies of a portion of the viral genome showed no significant abnormalities of the regulatory genes. In this individual, the combination of low viral load in the peripheral blood and a strong, responsive immune system is associated with long-term, disease-free coexistence with HIV-1 infection.

Asunto(s)

Infecciones por VIH/inmunología , VIH-1 , Citotoxicidad Celular Dependiente de Anticuerpos , ADN Viral/genética , ADN Viral/aislamiento & purificación , Anticuerpos Anti-VIH/sangre , Infecciones por VIH/complicaciones , Infecciones por VIH/microbiología , VIH-1/genética , VIH-1/aislamiento & purificación , Hemofilia A/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Fenotipo , Reacción en Cadena de la Polimerasa , Linfocitos T Citotóxicos/inmunología , Factores de Tiempo , Viremia/microbiología , Cultivo de Virus , Replicación Viral